Entity Common Stock, Shares Outstanding of Krystal Biotech, Inc. from 31 Oct 2017 to 11 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Krystal Biotech, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Oct 2017 to 11 Feb 2026.
  • Krystal Biotech, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 11 Feb 2026 was 29,232,189, a 1.5% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Krystal Biotech, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 29,232,189 +426,111 +1.5% 11 Feb 2026 10-K 17 Feb 2026 2025 FY
Q3 2025 28,997,519 +236,971 +0.82% 29 Oct 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 28,942,981 +213,031 +0.74% 30 Jul 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 28,898,680 +340,240 +1.2% 01 May 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 28,806,078 12 Feb 2025 10-K 19 Feb 2025 2024 FY
Q3 2024 28,760,548 +554,218 +2% 28 Oct 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 28,729,950 +735,773 +2.6% 29 Jul 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 28,558,440 +2,758,702 +11% 29 Apr 2024 10-Q 06 May 2024 2024 Q1
Q3 2023 28,206,330 +2,458,683 +9.5% 30 Oct 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 27,994,177 +2,329,890 +9.1% 31 Jul 2023 10-Q 07 Aug 2023 2023 Q1
Q1 2023 25,799,738 +164,600 +0.64% 01 May 2023 10-Q 08 May 2023 2023 Q1
Q3 2022 25,747,647 +3,509,663 +16% 31 Oct 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 25,664,287 +3,458,645 +16% 29 Jul 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 25,635,138 +3,430,511 +15% 29 Apr 2022 10-Q 09 May 2022 2022 Q1
Q3 2021 22,237,984 +2,530,364 +13% 29 Oct 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 22,205,642 +2,541,583 +13% 30 Jul 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 22,204,627 +4,818,818 +28% 30 Apr 2021 10-Q 10 May 2021 2021 Q1
Q3 2020 19,707,620 +2,399,230 +14% 30 Oct 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 19,664,059 +2,363,669 +14% 31 Jul 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 17,385,809 +2,942,240 +20% 30 Apr 2020 10-Q 04 May 2020 2020 Q1
Q3 2019 17,308,390 +2,879,474 +20% 31 Oct 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 17,300,390 +6,946,474 +67% 31 Jul 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 14,443,569 +4,133,954 +40% 30 Apr 2019 10-Q 07 May 2019 2019 Q1
Q3 2018 14,428,916 +4,191,669 +41% 31 Oct 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 10,353,916 31 Jul 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 10,309,615 30 Apr 2018 10-Q 07 May 2018 2018 Q1
Q3 2017 10,237,247 31 Oct 2017 10-Q 13 Nov 2017 2017 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.